Tara Biosciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 30-06-2024
- Paid Up Capital ₹ 3.00 Cr
as on 30-06-2024
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 21.75 Cr
as on 30-06-2024
- Satisfied Charges ₹ 7.49 Cr
as on 30-06-2024
- Revenue -12.04%
(FY 2021)
- Profit 181.71%
(FY 2021)
- Ebitda 9.92%
(FY 2021)
- Net Worth 10.77%
(FY 2021)
- Total Assets -7.46%
(FY 2021)
About Tara Biosciences
The Corporate was formerly known as Taara Medicare India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹21.75 Cr. The company has closed loans amounting to ₹7.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
Leela Sethi, Monika Singh, and Hitendra Yadav serve as directors at the Company.
- CIN/LLPIN
U85100DL2007PTC168544
- Company No.
168544
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Sep 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Tara Biosciences Private Limited offer?
Tara Biosciences Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Medical Tubes, Antibacterial Drugs, Ofloxacin Tablet IP, Kidney Drugs, Mannitol Injections, Injectable Products, Sterile Water, IV Fluids, Sodium Chloride Injection.
Who are the key members and board of directors at Tara Biosciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Leela Sethi  | Director | 13-Jan-2014 | Current |
| Monika Singh | Director | 30-Sep-2016 | Current |
| Hitendra Yadav | Director | 21-Sep-2007 | Current |
Financial Performance and Corporate Structure Insights of Tara Biosciences.
Tara Biosciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 12.04% decrease. The company also saw a substantial improvement in profitability, with a 181.71% increase in profit. The company's net worth Soared by an impressive increase of 10.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tara Biosciences?
In 2021, Tara Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Aug 2012 | ₹11.75 Cr | Open |
Corporation Bank Creation Date: 29 Aug 2012 | ₹10.00 Cr | Open |
Oriental Bank Of Commerce Creation Date: 14 Dec 2009 | ₹8.56 M | Satisfied |
How Many Employees Work at Tara Biosciences?
Tara Biosciences has a workforce of 129 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tara Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tara Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
